نتایج جستجو برای: induced pluripotent stem cells ipsc

تعداد نتایج: 2213628  

Journal: :International journal of molecular sciences 2018
Marina Gazdic Vladislav Volarevic C Randall Harrell Crissy Fellabaum Nemanja Jovicic Nebojsa Arsenijevic Miodrag Stojkovic

Spinal cord injury (SCI), a serious public health issue, most likely occurs in previously healthy young adults. Current therapeutic strategies for SCI includes surgical decompression and pharmacotherapy, however, there is still no gold standard for the treatment of this devastating condition. Inefficiency and adverse effects of standard therapy indicate that novel therapeutic strategies are req...

2016

Submit Manuscript | http://medcraveonline.com Abbreviations: CPEO: Chronic Progressive External Ophthalmoplegia; KSS: Kearns-Sayre Syndrome; MELAS: Mitochondrial Encephalopathy Lactic Acidosis Stroke-like Episodes; NARP: Neuropathy Ataxia Retinitis Pigmentosa; LHON: Leber’s Hereditary Optic Neuropathy; MERRF: Myoclonic Epilepsy and Ragged Red Fibers; iPSC: Induced Pluripotent Stem Cells; FIAU: ...

2017
Jared Carlson-Stevermer Ty Harkness Ryan Prestil Stephanie Seymour Gavin Knight Randolph Ashton Krishanu Saha

Reprogramming of human somatic cells to induce pluripotent stem cells (iPSCs) generates valuable precursors for disease modeling and regenerative medicine. However, the reprogramming process can be inefficient and noisy, creating many partially reprogrammed cells in addition to fully reprogrammed iPSCs. To address these shortcomings, we developed a micropatterned substrate that allows for dynam...

Journal: :Cell reports 2013
Marina E Emborg Yan Liu Jiajie Xi Xiaoqing Zhang Yingnan Yin Jianfeng Lu Valerie Joers Christine Swanson James E Holden Su-Chun Zhang

The generation of induced pluripotent stem cells (iPSCs) opens up the possibility for personalized cell therapy. Here, we show that transplanted autologous rhesus monkey iPSC-derived neural progenitors survive for up to 6 months and differentiate into neurons, astrocytes, and myelinating oligodendrocytes in the brains of MPTP-induced hemiparkinsonian rhesus monkeys with a minimal presence of in...

2017
Zhouhui Geng Patrick J Walsh Vincent Truong Caitlin Hill Mara Ebeling Rebecca J Kapphahn Sandra R Montezuma Ching Yuan Heidi Roehrich Deborah A Ferrington James R Dutton

Fidelity in pluripotent stem cell differentiation protocols is necessary for the therapeutic and commercial use of cells derived from embryonic and induced pluripotent stem cells. Recent advances in stem cell technology, especially the widespread availability of a range of chemically defined media, substrates and differentiation components, now allow the design and implementation of fully defin...

Journal: :Stem cells translational medicine 2015
Nikolett M Biel Katherine E Santostefano Bayli B DiVita Nihal El Rouby Santiago D Carrasquilla Chelsey Simmons Mahito Nakanishi Rhonda M Cooper-DeHoff Julie A Johnson Naohiro Terada

UNLABELLED Studies in hypertension (HTN) pharmacogenomics seek to identify genetic sources of variable antihypertensive drug response. Genetic association studies have detected single-nucleotide polymorphisms (SNPs) that link to drug responses; however, to understand mechanisms underlying how genetic traits alter drug responses, a biological interface is needed. Patient-derived induced pluripot...

2015
Courtney L Kagan Nicholas E Banovich Bryan J Pavlovic Kristen Patterson Irene Gallego Romero Jonathan K Pritchard Yoav Gilad

The advent of induced pluripotent stem cells (iPSCs) revolutionized Human Genetics by allowing us to generate pluripotent cells from easily accessible somatic tissues. This technology can have immense implications for regenerative medicine, but iPSCs also represent a paradigm shift in the study of complex human phenotypes, including gene regulation and disease. Yet, an unresolved caveat of the ...

2016
Carmen Unzu Marc Friedli Alexis Bosman Marisa E. Jaconi Barbara E. Wildhaber Anne-Laure Rougemont

Induced pluripotent stem cells (iPSC) are a most promising approach to the development of a hepatocyte transplantable mass sufficient to induce long-term correction of inherited liver metabolic diseases, thus avoiding liver transplantation. Their intrinsic self-renewal ability and potential to differentiate into any of the three germ layers identify iPSC as the most promising cell-based therape...

2016
Christina T. Thiesler Samanta Cajic Dirk Hoffmann Christian Thiel Laura van Diepen René Hennig Malte Sgodda Robert Weiβmann Udo Reichl Doris Steinemann Ulf Diekmann Nicolas M. B. Huber Astrid Oberbeck Tobias Cantz Andreas W. Kuss Christian Körner Axel Schambach Erdmann Rapp Falk F. R. Buettner

PMM2-CDG, formerly known as congenital disorder of glycosylation-Ia (CDG-Ia), is caused by mutations in the gene encoding phosphomannomutase 2 (PMM2). This disease is the most frequent form of inherited CDG-diseases affecting protein N-glycosylation in human. PMM2-CDG is a multisystemic disease with severe psychomotor and mental retardation. In order to study the pathophysiology of PMM2-CDG in ...

2013
Dennis Roop Jakub Tolar

Direct reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) provides an opportunityto develop novel personalized treatment options for numerous diseases and to advance current approachesfor cell-based drug discoveries and disease modeling. The ability to differentiate iPSCs into relevant celltypes is an important prerequisite for the successful development of i...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید